Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Feb:150:93-100.
doi: 10.1016/j.antiviral.2017.12.006. Epub 2017 Dec 14.

Research priorities for the discovery of a cure for chronic hepatitis B: Report of a workshop

Affiliations

Research priorities for the discovery of a cure for chronic hepatitis B: Report of a workshop

Timothy M Block et al. Antiviral Res. 2018 Feb.

Abstract

In early 2017, the Hepatitis B Foundation invited 30 experts in the fields of hepatitis B and liver cancer research to identify projects they deemed important to the goal of finding a cure for chronic hepatitis B and D and the diseases with which these viral infections are associated. They were also asked to identify general categories of research and to prioritize sub-project topics within those areas. The experts generally agreed on broadly defined areas of research, but there was usually little difference between the highest and lowest scoring projects; for the most part, all programs described in this document were considered valuable and necessary. An executive summary of this discussion was recently published (Alter et al., Hepatology 2017). The present manuscript reports the areas of research identified by the workshop participants, provides a brief rationale for their selection, and attempts to express differences among the priorities assigned to each area of research, when such distinctions were expressed.

Keywords: Antiviral therapy; Hepatitis B; Hepatitis D; Hepatocellular carcinoma.

PubMed Disclaimer

References

    1. Alfaiate D, Dény P, Durantel D, 2015. Hepatitis delta virus: from biological and medical aspects to current and investigational therapeutic options. Antivir. Res 122, 112–129. - PubMed
    1. Alter H, Block T, Brown N, Brownstein A, et al., 2017. Research Agenda for curing chronic hepatitis B virus infection. Hepatology 10.1002/hep.29509. (in press). - DOI - PMC - PubMed
    1. Bertoletti A, Kennedy PT, 2015. The immune tolerant phase of chronic HBV infection: new perspectives on an old concept. Cell. Mol. Immunol 12, 258–263. - PMC - PubMed
    1. Block T, Alter J, London WT, Bray M, 2016. A historical perspective on the discovery and elucidation of the hepatitis B virus. Antivir. Res 131, 109–123. - PubMed
    1. Block TM, Mehta AS, Fimmel CJ, Jordan R, 2003. Molecular viral oncology of hepatocellular carcinoma. Oncogene 22, 5093–5107. - PubMed

Publication types

MeSH terms

Substances